chr7-81745087-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000601.6(HGF):c.659G>A(p.Arg220Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000923 in 1,613,630 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000601.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HGF | ENST00000222390.11 | c.659G>A | p.Arg220Gln | missense_variant | Exon 6 of 18 | 1 | NM_000601.6 | ENSP00000222390.5 | ||
HGF | ENST00000457544.7 | c.644G>A | p.Arg215Gln | missense_variant | Exon 6 of 18 | 1 | ENSP00000391238.2 | |||
HGF | ENST00000444829.7 | c.659G>A | p.Arg220Gln | missense_variant | Exon 6 of 8 | 1 | ENSP00000389854.2 | |||
HGF | ENST00000453411.6 | c.644G>A | p.Arg215Gln | missense_variant | Exon 6 of 8 | 1 | ENSP00000408270.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251222Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135772
GnomAD4 exome AF: 0.0000972 AC: 142AN: 1461506Hom.: 1 Cov.: 31 AF XY: 0.0000880 AC XY: 64AN XY: 727068
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:2
The c.659G>A (p.R220Q) alteration is located in exon 6 (coding exon 6) of the HGF gene. This alteration results from a G to A substitution at nucleotide position 659, causing the arginine (R) at amino acid position 220 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
The p.Arg220Gln variant in HGF has been previously reported by our laboratory in 1 individual with hearing loss, and it has also been identified in 0.008% (11/128996) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the Arg220Gln variant is uncertain. ACMG/AMP criteria applied: PM2_Supporting. -
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at